EP 4114452 A1 20230111 - FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE PRODUCTION TO PROTECT AGAINST CORONAVIRUSES
Title (en)
FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE PRODUCTION TO PROTECT AGAINST CORONAVIRUSES
Title (de)
VOLLSYNTHETISCHE, LANGKETTIGE NUKLEINSÄURE ZUR IMPFSTOFFHERSTELLUNG ZUM SCHUTZ GEGEN CORONAVIREN
Title (fr)
ACIDE NUCLÉIQUE À CHAÎNE LONGUE ENTIÈREMENT SYNTHÉTIQUE POUR LA PRODUCTION DE VACCINS POUR LA PROTECTION CONTRE LES CORONAVIRUS
Publication
Application
Priority
- EP 20020092 A 20200303
- EP 20020240 A 20200520
- EP 2021055401 W 20210303
Abstract (en)
[origin: CA3170281A1] This invention describes a fully synthetic, long-chain nucleic acid that can be used in biotechnological manufacturing processes to produce envelope proteins, virus envelopes and fragments of virus envelopes of SARS-CoV-2 and related coronaviruses in highly purified form, which, as a vaccine protect against COVID-19 and other viral diseases
IPC 8 full level
A61K 39/12 (2006.01); C07K 14/005 (2006.01)
CPC (source: EP IL KR)
A61K 39/12 (2013.01 - EP IL); C07K 14/005 (2013.01 - EP IL KR); C12N 15/63 (2013.01 - KR); A61K 2039/53 (2013.01 - EP IL); C12N 2770/20022 (2013.01 - EP IL KR); C12N 2770/20034 (2013.01 - EP IL KR); C12N 2770/20051 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
AU 2021231238 A1 20221006; BR 112022017733 A2 20221129; CA 3170281 A1 20210910; CN 115768470 A 20230307; EP 4114452 A1 20230111; IL 296147 A 20221101; JP 2023517540 A 20230426; KR 20220150323 A 20221110; MX 2022010928 A 20221027
DOCDB simple family (application)
AU 2021231238 A 20210303; BR 112022017733 A 20210303; CA 3170281 A 20210303; CN 202180032734 A 20210303; EP 21709001 A 20210303; IL 29614722 A 20220901; JP 2022553056 A 20210303; KR 20227033430 A 20210303; MX 2022010928 A 20210303